Tetraphase Pharma (TTPH) Misses Q1 EPS by 2c

Tetraphase Pharma (NASDAQ: TTPH) reported Q1 EPS of ($0.66), $0.02 worse than the analyst estimate of ($0.64). Revenue for the quarter came in at $3 million versus the consensus estimate of $2.9 million.

For earnings history and earnings-related data on Tetraphase Pharma (TTPH) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49